ARCHIVES

Yarbro-Chabner Debate Continues

This article is from The Cancer Letter archive.

Vol. 09 No. 17 | April 29, 1983

Download PDF Visit The Full Archive

Related Articles

Interview With Departing NCI Director; Advice To His Successor.

July 9, 2010

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010

Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level

July 2, 1999

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

In Brief: DCT Board Rejects Move to Count Individual P01 Projects Toward The NIH Total Of 5,000 Grants

June 24, 1983